METHUSELAH ARCHIVE SOURCES / FTC-ASTHMACARE-KIT-CLOSING-LETTER-2014

Closing Letter: AsthmaCare Kit, FTC File No. 142-3102

regulatory notice · 2014
type:regulatory notice
year:2014
citation:Mary K. Engle, Associate Director, Division of Advertising Practices, Federal Trade Commission, Closing Letter to Dr. James Liu, DrNaturalHealing, Inc., Re: AsthmaCare Kit, FTC File No. 142-3102, September 3, 2014.
LINK
https://www.ftc.gov/system/files/documents/closing_letters/asthmacare-kit/140903asthmacarekitletter.pdf
SUMMARY
FTC closing letter addressed to 'Dear Dr. Liu' at DrNaturalHealing, Inc., 111 McCoy Street, Milford, DE 19963 (the same street address Tesla BioHealing, Inc. later used). FTC's Division of Advertising Practices investigated whether DrNaturalHealing violated FTC Act Section 5 in marketing the AsthmaCare Kit, a nasal irrigation device and homeopathic spray claimed to prevent or reduce asthma attacks and alleviate asthma symptoms. The letter states FTC staff were concerned the asthma-related claims were not adequately substantiated by competent and reliable scientific evidence, since the supporting evidence (that nasal irrigation can remove some viruses and allergens) did not support the specific claim that the kit could reduce attack frequency or symptom severity. FTC determined not to recommend enforcement action because Liu agreed to stop using the name 'AsthmaCare Kit' and stop making asthma-related claims, and because sales were very limited; the letter explicitly states this is not a determination that no violation occurred and reserves the right to take further action. Fetched and read directly from the FTC-hosted PDF (extracted text confirmed the quoted passages above).
NOTES

Text extracted directly from the FTC-hosted PDF. Establishes that James Liu, before founding Tesla BioHealing, Inc. in 2019, operated another health-products company (DrNaturalHealing, Inc.) at the identical Milford, Delaware address and received a prior FTC letter over unsubstantiated health claims for a different health device, after agreeing to drop the product name and the specific claims at issue.